Associated Papers
Prediction of esophageal cancer risk based on genetic variants and environmental risk factors in Chinese population.
Liu H et al.
Bmc Cancer, 2024
38755535 (PubMed )
Supplement: 12885_2024_12370_MOESM3_ESM.docx
Predicting drug response and toxicity in metastatic colorectal cancer: the role of germline markers.
Bignucolo A et al.
Expert Review of Clinical Pharmacology, 2022
Association of OGG1 and MTHFR polymorphisms with age-related cataract: A systematic review and meta-analysis.
Wu X et al.
Plos One, 2017
Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy.
Cecchin E et al.
The Pharmacogenomics Journal, 2011
Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05.
Boige V et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2010
Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease.
Seripa D et al.
Ageing Research Reviews, 2009
Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions.
Manuguerra M et al.
Carcinogenesis, 2007
Pharmacogenetics of cancer chemotherapy.
Abraham J et al.
Biochimica Et Biophysica Acta, 2006
Pharmacogenetics for individualized cancer chemotherapy.
Efferth T et al.
Pharmacology & Therapeutics, 2005
Rapid genotyping of human ERCC1 exon 4 polymorphism with fluorescence analysis using fluorophore-labeled hybridization probes and a lightcycler.
Yin J et al.
Biochemical Genetics, 2002
Low expression myeloperoxidase genotype negatively associated with Helicobacter pylori infection.
Hamajima N et al.
Japanese Journal of Cancer Research : Gann, 2001
Select a paper to view details